(Q39803118)

14 September 2017

1 reference

title

Cystic fibrosis and malnutrition (English)

1 reference

14 September 2017

0 references

0 references

H. P. Chase

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A381615

13 April 2023

M. A. Long

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A381615

13 April 2023

M. H. Lavin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A381615

13 April 2023

language of work or name

English

0 references

publication date

1 September 1979

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:S0022347679805041?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

https://api.elsevier.com/content/article/PII:S0022347679805041?httpAccept=text/plain

13 April 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

The Journal of Pediatrics

13 April 2023

published in

1 reference

14 September 2017

volume

95

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

337-347

1 reference

Research in cystic fibrosis (first of three parts)

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Research in cystic fibrosis (second of three parts)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Research in cystic fibrosis (third of three parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Comparative Effects of Antacids, Cimetidine and Enteric Coating on the Therapeutic Response to Oral Enzymes in Severe Pancreatic Insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Assessment of medium-chain triglyceride feeding in infants with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Effects of an artificial diet on growth of patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Abnormal levels of prostaglandins and fatty acids in blood of children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Aspects of bile acid metabolism in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

A RESPIRATORY DISEASE SYNDROME IN CHICKENS FED ESSENTIAL FATTY ACID DEFICIENT DIETS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

HYPOPROTEINEMIA AND EDEMA IN INFANTS WITH CYSTIC FIBROSIS OF THE PANCREAS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Edema and hypoproteinemia in infants with cystic fibrosis. The hypoalbuminemia sometimes seen is presumably secondary to malabsorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Serum Lipoprotein Concentrations in Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Blood and Liver Concentrations of Vitamins A and E in Children with Cystic Fibrosis of the Pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Bulging fontanelle as presenting sign in cystic fibrosis. Vitamin A metabolism and effect on cerebrospinal fluid pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Biochemical constituents of the dura mater in vitamin A deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Nutritional status of preschool children: Plasma vitamin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Absorption of vitamin A in patients with cystic fibrosis. Absorption is best with emulsified vitamin A alcohol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Rickets in adult cystic fibrosis with myopathy, pancreatic insufficiency and proximal renal tubular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

25-Hydroxycholecalciferol levels in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

The occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Vitamin E deficiency: A previously unrecognized cause of hemolytic anemia in the premature infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Hemolytic anemia and edema as the initial signs in infants with cystic fibrosis. Consider this diagnosis even in absence of pulmonary symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Influence of dietary vitamin E on prostaglandin biosynthesis in rat blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Muscular performance in cystic fibrosis patients and its relation to vitamin E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Studies of tocopherol deficiency in infants and children. VII. The effect of tocopherol on urinary, plasma and muscle creatine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Enhancement of the humoral immune response by vitamin E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Absorption of Different Doses of Fat Soluble and Water Miscible Preparations of Vitamin E in Children with Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Coagulation abnormalities in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Hypoprothrombinemic bleeding in a young infant. Association with a soy protein formula

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Hemorrhagic disease of the newborn. Breast feeding as a necessary factor in the pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Effect of sodium bicarbonate and pancreatin on the absorption of vitamin B12 and fat in pancreatic insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Malabsorption of Crystalline Vitamin B12in Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Malabsorption of Bile Acids in Children with Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Plasma-zinc in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Zinc status and vitamin A transport in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Zinc: A Trace Element Essential in Vitamin A Metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Absorption of inorganic iron- (59Fe2?) in relation to iron stores in pancreatic exocrine insufficiency due to cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Fatty acid and glucose metabolism in selenium deficient rats and lambs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Skeletal changes of copper deficiency in infants receiving prolonged total parenteral nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Screening for hyperlipidemia in childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

Characterization of the endogenous mediator(s) of serum zinc and iron depression during infection and other stresses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980504-1

inferred from DOI database lookup

7 January 2021

based on heuristic

The use of L-arginine and sodium bicarbonate in the treatment of malabsorption due to cystic fibrosis

6

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

Correction of essential fatty acid deficiency in newborn infants by cutaneous application of sunflower-seed oil

13 April 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

A therapeutic trial of fatty acid supplementation in cystic fibrosis

13 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

Dietary essential fatty acids in cystic fibrosis

13 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

Amino acid tolerance tests in children

13 April 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

Dietary Supplement and Nutrition in Children With Cystic Fibrosis

13 April 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

Depressed plasma retinol-binding protein levels in cystic fibrosis

13 April 2023

32

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

Vitamin E and the biological antioxidant theory

13 April 2023

43

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

Focal necrosis of striated muscle in an infant with cystic fibrosis of the pancreas and evidence of lack of absorption of fat-soluble vitamins

13 April 2023

47

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

Hemorrhagic Diathesis and Cystic Fibrosis in Infancy

13 April 2023

52

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

Therapy of cystic fibrosis of the pancreas

13 April 2023

62

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

The effect of oral zinc supplementation on plasma levels of vitamin A and retinol-binding protein in cystic fibrosis

13 April 2023

65

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

The Role of Zinc and Other Trace Metals in Pediatric Nutrition and Health

13 April 2023

67

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

The effect of zinc deficiency on the metabolism of retinol-binding protein in the rat

13 April 2023

69

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80504-1

13 April 2023

Identifiers

1 reference

14 September 2017

1 reference